Home
>
US Stocks
>
BridgeBio Pharma Inc
BridgeBio Pharma Inc
BBIO

BridgeBio Pharma Inc (BBIO)

$46.994.51%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
45.99
Today Low/High
45.57 / 46.99
52 Week Low/High
$27.47 / $73.5
Market Cap
$7.42B

Company Details

BridgeBio Pharma Inc. is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in 2015 to identify and advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. BridgeBio's pipeline of over 20 development programs includes product candidates ranging from early discovery to late-stage development.
Organisation
BridgeBio Pharma Inc
Headquaters
Palo Alto, California, US
Employees
391
Industry
Health Technology
CEO
Neil Kumar

Discover more

Frequently Asked Questions

What is BridgeBio Pharma Inc (BBIO) share price today?

Can Indians buy BridgeBio Pharma Inc (BBIO) shares?

How can I buy BridgeBio Pharma Inc (BBIO) shares from India?

Can Fractional shares of BridgeBio Pharma Inc (BBIO) be purchased?

What are the documents required to start investing in BridgeBio Pharma Inc (BBIO) stocks?

We are a SEBI registered investement advisor